About this trial
This study aims to examine the predictive value of metastatic gastric mesenteries, which contains metastatic lymph node, in 6 gastric mesenteries; and importantly, to further evaluate the relationship between the number of metastatic gastric mesenteries and prognosis in the gastric cancer patients who received D2+complete mesogastric excision (CME).
Eligibility criteria
Qualifiers
Aged older than 18 years and younger than 85 years
Primary gastric adenocarcinoma confirmed by preoperative pathology result
cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition
Patients who received gastrectomy with D2 lymphadenectomy plus complete mesogastric excision
Disqualifiers
Negative preoperative biopsy
Too late tumour stage or metastasis (cT4b/M1)
BMI>30 kg/m2
Total gastrectomy or proximal gastrectomy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Jichao Qin
Lead sponsor
First Affiliated Hospital of Zhejiang University
Sponsor institution
Zhejiang University
Collaborator